An Observational Study of Epilepsy: Biology and Outcomes Using Real-world Data
NCT05632978 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000
Last updated 2025-02-13
Summary
The goal of this observational study is to learn more about phenotypic, genetic, biochemical, neurophysiological and radiological patterns in epilepsy.
Participants will be asked to consent to use of clinical and paraclinical data (obtained during standard care) for research, and will be asked to donate blood samples at their routine clinic visits.
Conditions
Sponsors & Collaborators
-
Cardiff and Vale University Health Board
lead OTHER_GOV
Principal Investigators
-
Khalid Hamandi · Cardiff & Vale University Health Board
Eligibility
- Min Age
- 16 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-04-24
- Primary Completion
- 2032-12-31
- Completion
- 2032-12-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
Investigating Epilepsy: Screening and Evaluation
NCT03478852 ·Status: RECRUITING
-
Women With Epilepsy: Pregnancy Outcomes and Deliveries
NCT01259310 ·Status: COMPLETED
-
An Open-Label Extension Study to Evaluate the Safety and Effectiveness of RWJ 333369 in Patients With Epilepsy
NCT00210652 ·Status: COMPLETED ·Phase: PHASE2
-
Biology of Juvenile Myoclonic Epilepsy
NCT03400371 ·Status: RECRUITING
-
Study for the Diagnosis and Treatment of Drug-resistant Focal Epilepsies
NCT06794606 ·Status: RECRUITING
-
Study of Specimens Obtained During Epilepsy Surgery
NCT00025714 ·Status: COMPLETED
-
An Open-Label Extension Study of the Effectiveness and Safety of the Investigational Compound RWJ-333369 in Patients With Epilepsy
NCT00210522 ·Status: COMPLETED ·Phase: PHASE2
-
Cognitive Enhancement Intervention for Creating a Healthy L.I.F.E (Lifestyle Interventions for Epilepsy)
NCT05954182 ·Status: RECRUITING ·Phase: NA
-
Observational Study of Lamotrigine
NCT00299793 ·Status: COMPLETED
-
Precision Medicine in the Treatment of Epilepsy
NCT05450822 ·Status: RECRUITING
-
Naturalistic Study to Evaluate the Utilization of Care Services Associated to the Diagnostic Process of Any Kind of Epilepsy
NCT00522522 ·Status: COMPLETED
-
Open-label Study of Cenobamate Monotherapy in Adult Subjects With Newly Diagnosed or Recurrent Partial-Onset Epilepsy
NCT06453213 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Evaluation and Treatment of Patients With Epilepsy
NCT00013845 ·Status: TERMINATED
-
Big Data Construction and Biological Etiological Epidemiology Study of Children Epilepsy in China
NCT02969213 ·Status: UNKNOWN
-
Effect of Carbamazepine and Oxcarbazepine on Serum Neuron-specific Enolase and S100B in Focal Seizures
NCT02705768 ·Status: COMPLETED ·Phase: PHASE4
-
Rolandic Epilepsy Genomewide Association International Study
NCT03547050 ·Status: COMPLETED
-
Circulating microRNAs as Biomarkers of RESPIratory Dysfunction in Patients With Refractory epilePSY
NCT03419000 ·Status: COMPLETED ·Phase: NA
-
Long-Term Follow-Up of a Cohort of Participants Prescribed Epidyolex in France in a Real-life Setting
NCT05772429 ·Status: ACTIVE_NOT_RECRUITING
-
The Modified Ketogenic Diet for the Treatment of Pharmacoresistant Epilepsy in Adults
NCT03425110 ·Status: UNKNOWN
-
A Study to Assess utiLity of BIoEP as an Early Prognostic Indicator for Predicting Anti-Seizure Medication (ASM) Efficacy
NCT06354868 ·Status: NOT_YET_RECRUITING
-
Genetic Diagnosis and Personalized Medicine for Patients With Epilepsy
NCT06321822 ·Status: RECRUITING ·Phase: NA
-
A Study to Investigate How Effective, Safe and Tolerable the Drug NBI-921352 is When Used With Anti-seizure Medications in Adults With Focal Onset Seizures
NCT05159908 ·Status: COMPLETED ·Phase: PHASE2
-
Drug Resistant Epilepsy: Clinical and Genetic Study
NCT04166305 ·Status: UNKNOWN
-
Efficacy and Safety of Perampanel in the Treatment of Refractory Status Epilepticus
NCT05684978 ·Status: TERMINATED ·Phase: PHASE4
-
Study of Predictors of Response to Anti Epilepsy in Epilepsy
NCT02883712 ·Status: TERMINATED